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Neuregulins are a family of proteins expressed in the developing brain and in brain regions that continue to undergo neurogenesis in adult
animals.We investigated the effects of neuregulins on embryonic neural stem cells (NSCs) isolated fromE11mouse telencephalon. Treatment of
basic fibroblast growth factor (bFGF)-expanded neurosphere cultures with the EGF-like domain of neuregulin1-h1 (NRG-1177–244) resulted in
a 4-fold increase of bromodeoxyuridine (BrDU)-labeled cells, suggesting that NRG-1 stimulated proliferation. The majority of the BrdU-
positive cells co-labeled with an antibody against MAP2, indicating that the proliferating cells were neuronal. No BrDU labeling was seen in
GFAP- or O4-positive cells. In NRG-1-treated cultures, many of the MAP2-positive cells co-labeled with an anti-nestin antibody, suggesting
that these cells are neuron-restricted progenitors (NRPs). Few MAP2/nestin-positive cells were seen in control cultures. The increase in the
number of neuronal cells in NRG-1-treated cultures was due to increased proliferation of MAP2-positive cells rather than the regulation of cell
survival or fate determination. These results suggest that neuregulins are mitogenic to NRPs, thus endogenous neuregulins may play important
roles during CNS neurogenesis.
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Neural stem cells (NSCs) of the CNS are patterned in vivo
to generate neurons, oligodendrocytes, and astrocytes
(McKay, 1997; Ostenfeld and Svendsen, 2003; Panchision
and McKay, 2002; Qian et al., 2000; Sauvageot and Stiles,
2002). In vitro, pluripotent NSCs generate lineage-restricted,
self-renewing neuron-restricted progenitors (NRPs), and
glial-restricted progenitors (GRPs), which subsequently
develop into fully differentiated neuron and glial cells,
respectively. NRPs are mitotically active and electrically
immature, and they express only a subset of neuronal
markers. NRPs undergo additional changes to develop into0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.04.038
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E-mail address: bford@msm.edu (B.D. Ford).mature, functional neurons (Kalyani et al., 1997; Mayer-
Proschel et al., 1997; Mujtaba et al., 1999; Svendsen et al.,
1999). NSCs, NRPs, and GRPs that undergo self-renewal in
defined medium, and differentiate into multiple neural
phenotypes in mass culture previously have been isolated
from mouse neural tubes (Mujtaba et al., 1999).
When isolated, neuroepithelial NSCs are maintained in
culture in the absence of a substrate that supports adhesion,
cells form neurospheres (Kalyani et al., 1997; Mayer-
Proschel et al., 1997; Mujtaba et al., 1999; Svendsen et al.,
1999). Neurospheres contain a relatively homogeneous
population of NSCs that undergo self-renewal in response
to either bFGF or EGF. It was observed, however, that after
mitogen withdrawal, the NSCs were unable to undergo
neuronal differentiation directly (Ostenfeld and Svendsen,
2004). These cells emerged from the neurosphere as NRPs.
These NRPs were required to go through one or more rounds283 (2005) 437 – 445
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neurons. The initiation of neurogenesis is modulated by
multiple environmental signals, including peptide growth
factors (McKay, 1997; Ostenfeld and Svendsen, 2003;
Panchision and McKay, 2002).
Neuregulins and their receptors are expressed early in the
developing brain in regions undergoing proliferation or
neurogenesis (Corfas et al., 1995). This suggests a role for
neuregulins in the regulation of neurogenesis in the devel-
oping central nervous system (CNS). Moreover, there is
continued expression of neuregulin-1 (NRG-1) and its
receptors in adult animals in regions that continue to undergo
neurogenesis, such as the hippocampal dentate gyrus and the
subventricular zone (SVZ) (Pinkas-Kramarski et al., 1997;
Steiner et al., 1999). Therefore, neuregulins may play similar
roles in neurogenesis in the mature nervous system. Targeted
null mutations of the gene for NRG-1 or its receptors (erbB2
and erbB4) show disruptions in CNS development at
embryonic day 10.5 (E10.5) (Kramer et al., 1996; Meyer
and Birchmeier, 1995). This unfortunately limits the study of
the functions of neuregulins in neural development since
death of the knockouts precedes neurogenesis.
It has been reported that NSCs alter their properties over
time and undergo distinct phases of development. In vivo,
neurogenesis precedes the differentiation of oligodendro-
cytes and astrocytes (Abney et al., 1981; Frederiksen and
McKay, 1988; Hirano and Goldman, 1988); therefore, NSCs
isolated from early stage embryos mainly contained NSCs
that developed into neurons while NSCs from later-stage
embryos generate both neurons and glia (Qian et al., 2000;
Sauvageot and Stiles, 2002). Although a few studies have
demonstrated a role for neuregulins in the regulation of
multipotent E14 mouse NSC cultures and NSCs from adult
hippocampus (Calaora et al., 2001; Kornblum et al., 2000),
the involvement of NRG-1 in the control of NRP that have
committed to a neuronal lineage has not been reported. In the
present study, we examined the effects of NRG-1 on NSCs
and NRPs generated from E11 mouse telencephalon. Our
results provide evidence that neuregulins regulate the
proliferation of NRPs, suggesting an important role for
neuregulins in the early stages of brain development.Materials and methods
Neuregulin-1h EGF-like domain (NRG-1; residues
177–244) was purchased from R&D Systems (Minneap-
olis, MN). Dulbecco’s Modified Eagle’s Medium with F12
supplement (DMEM/F-12) was obtained from Life Tech-
nologies (Gaithersburg, MD). Transferrin, progesterone,
selenium, putrescine, polyornithine, EGF, and FGF were
obtained from Sigma (St. Louis, MO). Secondary anti-
bodies conjugated to the fluorophore indocarbocyanine
(Cy3 1:500), fluorescein isothiocyanate (FITC 1:200), or
AMCA (1:50) were purchased from Jackson Immuno-
chemicals (Westgrove, PA).Primary neurosphere cultures
Embryos obtained from timed pregnant Swiss Webster
mice (Taconic Farms, Germantown NY) at embryonic day 11
(E11) were placed in ice-cold Hanks’ balanced salt solution
(HBSS). Under a dissection microscope, skin and meninges
were removed, and the telencephalon dissected and placed in
ice-cold HBSS. Tissues were then incubated in 0.1% trypsin
at 37-C for 5–10 min and washed thoroughly in HBSS. The
generation of NSCs is similar to that described by Reynolds
(Reynolds and Weiss, 1996). Briefly, tissues were triturated
using a 200-Al pipette in serum-free growth medium (GM)
containing DMEM/F12 including HEPES (5mM), glucose
(0.6%), glutamine (2.5mM), sodium bicarbonate (3 mM),
insulin (25Ag/ml), transferrin (100 Ag/ml), progesterone (20
nM), putrescine (100AM), and sodium selenite (30 nM). Cells
were washed and the pellets were resuspended in 25-ml flasks
to a cell density of 1  106 cell/10 ml in serum-free GM
containing 20 ng/ml bFGF. Cultures were maintained in 37-C
incubators with 5% CO2 and 95%O2. bFGF was added to the
cultures every 2 days. In the absence of a substrate that
supported adhesion, cells formed neurospheres after 5 to 7
days in bFGF-supplemented medium. Free-floating neuro-
spheres in each culture were passaged at 7 days. For
passaging, culture medium containing floating neurospheres
was collected in 15-ml tubes and centrifuged at 1000 rpm.
The tissue pellet was incubated in 0.1% trypsin for 5–10 min
at 37-C, and then washed and triturated using 200-Al pipettes
in GM. The dissociated cell suspensions were then plated in
fresh GM containing bFGF to generate new neurospheres
(secondary neurosphere). All neurospheres used for examin-
ing the actions of NRG-1 were passaged at least once.
Plating spheres
Sterile German glass coverslips in 24-well plates (Nun-
clon) were incubated overnight at 37-C in a solution of poly-
l-ornithine (15 Ag/ml) in phosphate-buffered saline (PBS).
The coverslips were rinsed with PBS and then coated with
fibronectin (1 Ag/ml) for at least 6 h. Neurospheres, after 1–2
passages, were transferred onto the coated coverslips, and
incubated in serum-free GM in the presence of bFGF. Cells
continued to divide and migrate out of neurospheres to form a
monolayer. Neurospheres were then treated with NRG-1 by
rinsing free of bFGF and adding fresh GMwith NRG-1 for an
additional 4–5 days. The quantification was performed in the
sphere outgrowth areas.
Single clone cultures
Single clone cultures were obtained after the first passage.
Following dissociation of neurospheres, cells at very low
density were transferred to a 100-mm petri dish. Under the
dissection microscope, single cells were transferred directly
onto glass coverslips (one cell/coverslip) by using a micro-
capillary pipette connected to an aspirator tube. The glass
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nectin in 24-well plates. Cells were cultured in serum-free
medium with 20 ng/ml bFGF. More than 90% of cells
survived and 5–15% of them could generate clones under
these culture conditions. After 5–7 days, clones were treated
by rinsing free of bFGF and adding fresh mediumwith NRG-
1 for an additional 5 days.
Immunohistochemistry
Cells were fixed with 4% paraformaldehyde for 30 min at
room temperature and washed three times in PBS buffer.
Cultures were subsequently processed for immunocytochem-
ical staining using various antibodies. A monoclonal anti-
body against MAP2abc (1:500 dilution; Sigma), polyclonal
antiserum against GFAP (1:100 dilution; Chemicon, Teme-
cula, CA), and monoclonal antibody against O4 (1:10,
Chemicon) were used to identify neurons, astrocytes, and
oligodendrocytes, respectively. Monoclonal or polyclonal
antibodies against nestin (1:50 Developmental Studies
Hybridoma Bank, Iowa City, IA) were used to identify NSCs
and NRPs. Briefly, fixed cultures were blocked by incubation
in PBS with 5% normal goat serum and 0.2% Triton X-100 at
room temperature for 1 h. Cells were then incubated with
primary antibody for either 2 h at room temperature or
overnight at 4-C. Cells were washed four times with PBS,
then incubated with secondary antibody for 1 h at room
temperature. When labeling oligodendrocytes, Triton X-100
was excluded from the assay buffer.
Evaluation of cell viability
Neurospheres were dissociated by 0.025% trypsin-EDTA.
Single-cell suspensions were plated on glass coverslips pre-
coated with poly-l-ornithine and fibronectin at a density of
25,000 cells/cm2. Cells were grown in serum-free culture
medium in the absence or presence of 5 nMNRG-1. Analysis
was performed after 2, 4, 6, 8, and 10 days. We assessed cell
survival by using a Viability Assay Kit (Molecular Probes,
Eugene, OR). The kit comprised two probes: calcein AM and
ethidium homodimer-1. Calcein AM is a fluorogenic esterase
substrate that is hydrolyzed to a green fluorescent product.
Thus, green fluorescence is an indicator of cells that have
esterase activity as well as an intact membrane to retain the
esterase products. Ethidium homodimer-1 is a high-affinity,
red fluorescent nucleic acid stain that is only able to pass
through the compromised membranes of dead cells. The
reagents were simultaneously added to the cell cultures,
which were then incubated for 30–45 min. Results were
analyzed by fluorescence microscopy to count the cells with
green or red fluorescence labels.
BrDU labeling and detection
To label dividing cells with 5V-bromodeoxyuridine
(BrDU), cultures were incubated with 100 AM BrDU for24 h prior to fixation. After fixing with 4% paraformalde-
hyde for 30 min, cells were incubated with 2 N HCl for 20
min at room temperature to denature the double-stranded
DNA and increase the access of BrDU antiserum. Follow-
ing this, the cultures were neutralized with 0.1 M sodium
borate buffer for 10 min, rinsed in PBS, and incubated with
FITC-conjugated anti-BrDU antibody for 1 h at room
temperature. For dual-staining experiments, cells were first
stained with either anti-MAP2 or GFAP, and then processed
for BrDU staining. Sections were mounted with an antifade
medium containing the nuclear counterstain DAPI (4V,6-
diamidino-2-phenylindole).
[3H]Thymidine incorporation assay
Cell suspensions from dissociated neurospheres were
plated onto poly-l-lysine- and laminin-coated 48-well
Nunclon culture dishes at a density of 80,000 cells/well.
After 4–5 days in the presence of bFGF, cells were rinsed free
of bFGF and incubated with 5 nM NRG-1 for an additional
4–5 days. Solutions were removed and medium-containing
[3H]thymidine (1 ACi/ml) was added for 4 h at 37-C. At the
end of the incubation, cells were fixed with methanol at
20-C for 10 min. Cells were then washed three times with
10% trichloroacetic acid (TCA) and lysed with 0.1 M NaOH/
0.1% sodium deoxycholate. Lysates were transferred to vials
containing scintillant and vigorously vortexed. Radioactivity
was measured by liquid scintillation counting.Results
The effect of NRG-1 on NSCs isolated from E11 mouse
telencephalon
To investigate the effects of NRG-1 in multipotent NSCs,
we isolated the telencephalon of E11 mouse embryos and
cultured the dissociated cells as neurosphere cultures. In the
present study, we treated cultures with the EGF-like domain
of neuregulin-1h (NRG-1). The EGF-like domain contains
the receptor-binding portion of the molecule and has been
shown to display all the known biological activities of the
full-length neuregulins (Fischbach and Rosen, 1997; Holmes
et al., 1992). After 5–7 days in bFGF GM, the cells formed
neurospheres and expressed nestin, an intermediate filament
protein present in NSCs and NRPs in the developing CNS.
We first examined whether the addition of NRG-1 to cell
suspensions obtained from E11 mouse cortical tissue would
generate neurospheres in the absence of bFGF. After 7 days in
culture, we did not see a significant difference in the total
number or size of neurospheres in the NRG-1-treated group
compared with the untreated group (data not shown). This
result demonstrated that NRG-1 alone, unlike bFGF, could
not generate neurospheres. When bFGF-generated neuro-
spheres were plated onto coated coverslips in the presence of
bFGF, cells continued to divide and migrate out of the sphere
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migrating cells differentiated into cells expressing neuronal,
astrocyte, and oligodendrocyte markers. Neuronal cells were
identified by labeling with the anti-MAP2 antibody (red,
Figs. 1b, c). Oligodendrocytes were identified with an
antibody directed against O4 (green, Fig. 1b) and astrocytes
were identified with an antibody directed against GFAP
(green, Fig. 1c). Morphologically, these MAP2-positive cells
appeared neuronal and showed: (i) a spherical, ovoid, or
pyramidal shaped soma; (ii) phase-bright appearance; (iii)
branching processes (presumably dendrites) arising from the
soma (Fig. 1d; same field as Fig. 1c).
NRG-1 increases the proliferation of MAP2-positive cells in
neurosphere cultures
The actions of NRG-1 on bFGF-generated neurospheres
were examined by plating neurospheres on coverslips as
described above. Neurospheres were cultured in the absence
or presence of 5 nM NRG-1 for 5 days, then co-labeled with
BrDU and MAP2 or GFAP antibodies. After 5 days of
treatment with 5 nM NRG-1, a dramatic increase in the
number of cells surrounding the core of the neurosphere was
observed in NRG-1-treated cultures (Figs. 2b, d) as compared
to control (Figs. 2a, c). A 44 T 3.3% increase in [3H]thymi-
dine incorporation was seen in NRG-1-treated cultures (Fig.
2e) that paralleled the increase in the total number of cells
(Fig. 2f). More MAP2 and BrDU co-labeled cells (yellow)Fig. 1. NSCs migrate out from plated bFGF-generated neurospheres and differen
shows cells migrating from attached neurosphere (a). Neurons were identified
Oligodendrocytes were identified with an antibody directed against O4 (b; green)
green). (d) Phase image of field shown in panel c. Scale bar is 50 Am in panel awere found both in the central core and peripheral area of
NRG-1-treated neurospheres, but few double-labeled cells
were seen in the control. There was a 2.5-fold increase in
MAP2-positive cells, but no increase in MAP2-negative
cells, suggesting that the majority of additional cells in NRG-
1-treated cultures were neuronal (Fig. 2f).
To further characterize the effect of NRG-1 on NSCs,
neurospheres were cultured in the absence or presence of 1 or
5 nM NRG-1, then co-labeled with BrDU and MAP2 or
GFAP antibodies. After 5 days, there was a 4-fold increase in
the number BrDU-labeled cells (green) in the neurosphere
outgrowth area in 5 nM NRG-1-treated group (Figs. 3b, c,
and d) compared to control (Fig. 3a). A smaller, but
significant increase was also observed with 1 nM NRG-1
treatment demonstrating a dose-dependent response of cells
to NRG-1 (Fig. 3d). Most of the BrDU-positive cells co-
labeled with the MAP2 (red, Fig. 3b), but not the GFAP
antibody (red, Fig. 3c). Therefore, the increased proliferation
was specific for neuronal cells and not in GFAP-positive
astrocytes. The increase in number of MAP2-positive cells
that co-labeled with BrDU was parallel to the increase of
BrDU-positive cells, suggesting that most of the cells
proliferating in response to NRG-1 were neuronal. In cultures
maintained for 8 days after withdrawal of bFGF, virtually no
cells showed BrDU incorporation in control cultures. By that
time point, most cells had differentiated and lost the ability to
proliferate. However, numerous BrDU-positive neurons were
present in the NRG-1-treated group, suggesting that NRG-1tiate into neurons, astrocytes, and oligodendrocytes. Phase contrast image
by staining with an antibody directed against MAP2 (b and c, red).
and astrocytes were identified with an antibody directed against GFAP (c;
and 10 Am in panels b–d.
Fig. 2. NRG-1 increases the number of MAP2-positive cells. Five days after plating, neurospheres were rinsed free of bFGF and cultured for additional 5 days
in the presence (b, d) or absence of 5 nM NRG-1 (a, c). Treatment with NRG-1 resulted in an increase in the number of MAP2- (red), BrDU- (green), and
double-labeled (yellow) cells in the central core and outgrowth area. Few double-labeled cells were seen in the control. Scale bar is 100 Am. An increase in cell
proliferation also was seen when measuring [3H]thymidine incorporation (e). The data graphed in panel f show the percent increase (mean T SEM) in the
number of cells from 20 random fields in the peripheral area of neurospheres (10–15 neurospheres), in control and NRG-1-treated groups. Data show a
representative result from one culture preparation of 4 independent experiments. The statistical significance of differences was tested by two-sample t test.
Fig. 3. NRG-1 increases the number of proliferating MAP2-positive cells. Most BrDU-positive cells (green) are double-labeled with MAP2 antibody (red; areas
of co-localization are yellow) in the NRG-1-treated group (b), but not in controls (a). BrDU-positive nuclei were not seen in cells labeled with an anti-GFAP
antibody (c). Scale bar is 50 Am. The total number of BrDU-positive and BrDU + MAP2 co-labeled cells increased in a dose-dependent manner in cultures
treated with both 1 nM and 5 nM NRG-1 (d). The asterisks indicate that the values are significantly different from control ( P < 0.001).
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Fig. 4. NRG-1 increases the proliferation of NRPs. BrDU-positive neurons
in NRG-1 treated cultures displayed round cell bodies with a few, short
processes (a). Most of the MAP2-positive neurons (red) were also labeled
by nestin (green, double labeled cells are yellow) in NRG-1-treated
culture (b). Neurons in the control group were pyramidal in morphology
and displayed long neurites and did not co-express nestin (c). Scale bar is
20 Am.
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not shown). Under our culture conditions, few cells were
labeled with GFAP and O4 in control cultures, or after
treatment with NRG-1; therefore, the cells that labeled with
BrDU alone were likely undifferentiated NSCs.
BrDU-positive neurons in NRG-1-treated cultures
appeared less mature than in control cultures. These cells
displayed round cell bodies with a few, short processes (Fig.
4a). We double labeled those cells with antibodies against
MAP2 and nestin and found that most of the MAP2-positive
neurons were also labeled by nestin in NRG-1 treated culture
(Fig. 4b). In contrast, neurons in the control group were
pyramidal in morphology and displayed long neurites (Fig.
4c). These neuronal cells did not co-express nestin as seen
with NRG-1 treatment. Thus, it appears that the increased
number of MAP2-positive cells after NRG-1 treatment was
due to an increase in the number of NRPs.
NRG-1 increases proliferation rather than survival
The increased production of neurons could be altered (1)
by affecting the proliferation of NRPs, (2) by affecting the
differentiation of NSCs into neurons, or (3) by altering the
survival of neuronal cells. Increased proliferationmight result
in an increase in the total number of cells as well as in the
number of proliferating MAP2-positive cells; increased
differentiation might result in an increase in the number of
MAP2-positive cells within the same total population of cells;
increased survival might result in an increase in MAP2-
positive cells, but not necessarily cells co-labeled with BrDU
or nestin. To determine whether the increase in the number of
NRPs induced by NRG-1 was due to the increase of cell
survival, we evaluated cell viability by using a Viability
Assay Kit (Molecular probes). Our results showed that the
total number of cells increased after 4 days in the cultures
(Fig. 5a). The number of live cells was greater in NRG-1-
treated group compared to control. Twice as many live cells
were present in the NRG-1 group after 8 days. There was no
difference in the number of dead cells in control or NRG-1-
treated cultures at most time points (Fig. 5b). This result
suggests that NRG-1 stimulated proliferation rather than cell
survival.
NRG-1 increases the proliferation of MAP2-positive cells in
clonal cultures
In order to study whether NRG-1 influenced cell lineage
or promoted the differentiation of NSCs into neurons, the
effects of NRG-1 were studied in single clone cultures.
Single NSCs were dissociated from bFGF-generated neuro-
spheres and plated on poly-l-ornithine- and fibronectin-
coated glass coverslips in serum-free medium including
bFGF. The cells divided and generated clones (Figs. 6a–c).
A total of 52 clones in control and 72 clones in NRG-1
treated groups were quantified from 3 separate experiments.
A significant increase in total number of cells was observedafter treatment with NRG-1 (Fig. 6f) compared to control
(Fig. 6d). The average number of cells generated from each
clone was 69 T 7 in control and 92 T 9 in NRG-1-treated
groups. Under our culture conditions, all clones produced
more than one type of cell based on morphology and
immunolabeling. Labeling of clones with antibodies against
neuronal and glial cell markers revealed that the clones
mainly contained MAP2-positive cells (Figs. 6e, g). GFAP-
and O4-positive cells were rarely seen. The total number of
MAP2-positive cells per clone was increased after treat-
ment with NRG-1 by nearly 2-fold (36 T 4) in the NRG-1
Fig. 5. NRG-1 increases cell proliferation but not cell survival. NSCs were
dissociated from bFGF-generated neurospheres and cultured at low density
(see Materials and methods). Analysis was performed after 2, 4, 6, 8, and 10
days after treatment with NRG-1. By day 4, the total number of live cells
was greater in the NRG-1 group than in control (a). There is no decrease in
the total number of dead cells (b). Experiments were performed twice; data
show the mean T SEM of 20 fields obtained from duplicate coverslips in
control and NRG-1-treated cultures.
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No significant difference in the number of MAP2-negative
cells was observed. The ratio of neurons per clone
increased from 25.9 T 1.7% in control to 36.2 T 1.8% in
NRG-1 treated group, suggesting that NRG-1 increased the
proliferation of MAP2-positive cells and did not direct
MAP2-negative NSCs to a neuronal lineage.Discussion
NRG-1 is one of many growth factors that influence
neural development (Buonanno and Fischbach, 2001;
Lemke, 1996; Ma et al., 1998; Meyer and Birchmeier,
1995). Multiple roles of neuregulins have been reported,
such as in the development of the neural crest (Kramer et al.,
1996; Meyer and Birchmeier, 1995; Shah et al., 1994),
myocardium(Kramer et al., 1996; Meyer and Birchmeier,1995; Shah et al., 1994), Schwann cells (Garratt et al.,
2000a), and oligodendrocytes (Canoll et al., 1999; Vartanian
et al., 1999). In this study, we demonstrated a role for NRG-
1 in the regulation of embryonic NRP cells. These results
suggest that neuregulins may play additional roles in the
early development of the nervous system by regulating the
formation of neurons in the brain.
In the developing CNS, NSCs comprise a self-renewing
cell population able to generate neurons, astrocytes, and
oligodendrocytes (McKay, 1997; Ostenfeld and Svendsen,
2003; Panchision and McKay, 2002; Qian et al., 2000;
Sauvageot and Stiles, 2002). A continuous supply of bFGF
is necessary to repress differentiation and to maintain a
population of rapidly dividing, nestin-positive NSCs. With-
drawal of the bFGF mitogen initiates differentiation within
24 h and results in a marked decrease in the number of
nestin-positive cells (Ostenfeld and Svendsen, 2004;
Vicario-Abejon et al., 1995). In our study, the strong
mitogenic effect of NRG-1 was only obvious after bFGF
withdrawal, suggesting the emergence of NRPs is necessary
for NRG-1 action. The addition of NRG-1 leads to a
significant increase in the number of cells co-expressing
MAP2 and nestin, indicating that NRG-1 either directly
induces proliferation of NRPs and/or prevents the differ-
entiation of NRPs into mature neurons and allows them to
continue proliferating in response to extrinsic or intrinsic
mitogenic signals. The latter is consistent with a previous
report that endogenous NDF/NRG-1, acting through the
erbB4 receptor, inhibits neuronal differentiation and neurite
outgrowth in E17 rat brain cultures and neuronal P19
teratocarcinoma cells (Pinkas-Kramarski et al., 1997).
As previously stated, mouse or rat NSCs isolated from
early developmental periods differentiate into neurons,
whereas those isolated from late prenatal and early postnatal
stages differentiate into glia as wells as neurons (Qian et al.,
2000; Sauvageot and Stiles, 2002). Therefore, it was not
unexpected that under our culture conditions, we found few
cells labeled by GFAP and O4. We assume that cells isolated
from the E11 mouse telencephalon mainly contained NSCs
that developed into NRPs and neurons. Previous studies of
NRG-1 on NSCs found that NRG-1 did not generate
neurospheres from E17 or P1 rat striatum (Kornblum et
al., 2000). We saw a similar result with E11 mouse NSCs.
NRG-1 also increased the size and number of neurospheres
formed from P0 rat hippocampus (Lai and Feng, 2004) and
an inhibitor of NRG-1 (soluble erbB3) decreased the size
and number of neurospheres formed from E14 mouse
striatum (Calaora, 2001). This is further evidence of an
effect of NRG1 on neural stem cells. However, it is difficult
to specify the type of stem cell within the neurosphere that
responded to NRG-1 since the NSCs were from mice or rats
at very different developmental stages. Neither group
observed an increase in the proliferation of NRPs following
NRG-1 treatment.
Several recent studies indicate, using mutant mice and
soluble inhibitors of NRG-1, that endogenous NRG-1 can
Fig. 6. NRG-1 increases the number of MAP2-positive cells in single clone cultures. Single NSCs were dissociated from bFGF-generated neurospheres and
plated on glass coverslips in serum-free medium with 20 ng/ml bFGF (a). Clones are shown after 4 (b) and 7 (c) days in culture. After withdrawal of bFGF,
control medium or NRG-1 was added to the medium for additional 5 days. In controls (d, e), there are few MAP2-positive neurons (red) compared to the NRG-
1-treated group (f, g). Scale bar is 20 Am.
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vivo (Anton et al., 1997; Calaora et al., 2001; Garratt et al.,
2000b; Kornblum et al., 2000; Park et al., 2001; Rio et al.,
1997; Schmid et al., 2003). NRG-1 is endogenously present
in neurogenic regions, and it is well known that neuregulins
are highly expressed in cholinergic systems and in the
hippocampus (Corfas et al., 1995; Kramer et al., 1996;
Marchionni et al., 1993; Meyer and Birchmeier, 1995; Meyer
et al., 1997). In addition, expression of NRG-1 and its
receptors is upregulated after brain injury (Erlich et al., 2000;
Tokita et al., 2001) and stroke in vivo (Parker et al., 2002).
Interestingly, proliferation in the adult hippocampal dentate
gyrus has been reported to be influenced by factors associated
with stress and neural activity. Seizure activity induced by
stimulation of the perforant pathway leads to a dramatic
increase in cell proliferation in the dentate gyrus and the
formation of new granule neurons in adult rats (Parent et al.,
1997). Epileptic seizures induced by kainic acid results in
increased NRG-1 expression in limbic cortical areas, hippo-
campus, and amygdala (Eilam et al., 1998), raising the
possibility that NRG-1 is an endogenous regulator for NRP
function. It will be interesting to determine whether NRG-1
induced by neural activity or brain injury influences theproliferation of NRPs in vivo in an attempt to repair the
injury.
In summary, these data demonstrate that NRG-1 acts as a
mitogen specifically for neuron-restricted progenitor cells.
The involvement of neuregulins in the neurogenesis or
proliferation of NRPs is of critical interest, and resolution of
this issue may suggest mechanisms of controlling stem cell
states during development and in adult animals after
transplantation (Memberg and Hall, 1995). The mechanism
by which NRG-1 modulates neuronal proliferation remains
to be determined. Future studies will further characterize the
role of endogenous neuregulins in neurogenesis in develop-
ment and after neuronal injury.References
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